Respiratory Devices Market: Overview

As per a report published by the National Institutes of Health (NIH), approximately 12 million adult population is diagnosed with Chronic Obstructive Pulmonary Disease (COPD) annually in the U.S. Further, 120, 000 people die of the cause. As per a statistics provided by Global Asthma Network (GAN), approximately 334 million are, reportedly, suffering from COPD across the globe. In addition, as per data given by the WHO, 3 million people die due to COPD around the world.

Every report by prominent health organization is signaling towards growing incidence of Chronic Obstructive Pulmonary Disease across the world and its adverse impact on health of the people. Some of the significant cases of COPD include respiratory allergies, asthma, occupational lung diseases, and pulmonary hypertension. Prevalence of such diseases is witnessed in middle- and low-income countries.

global-respiratory-devices-market.jpg

Dramatic rise in respiratory diseases and subsequent increase in patient pool due to COPD are major factors accelerating uptake of respiratory therapy and respiratory therapy devices. Use of respiratory devices minimizes the risk of heart failure, enhance breathing patterns, and improves mental stamina.

These factors, altogether, are contributing to expansion of the respiratory devices market.

As per a report published by Transparency Market Research, the respiratory devices market is anticipated to growth at a moderate CAGR of 6.5% between 2018 and 2026 (forecast period). In the year 2017, the respiratory devices market stood at a value of US $ 17 billion. If the market scales at predicted CAGR, then the market size is projected to grow equivalent to US$ 31.0 Bn by the end of 2026.

Rising prevalence of sleep apnea and COPD, healthy competition among key player, investment from various stakeholders are major driving factors likely to fuel the global respiratory device and uncertain regulations by government bodies may interfere with the market growth during the forecast period.

Market Players Focusing to Diversify Product Portfolio in order to Gain Wide Customer Traction

Rising awareness regarding application of respiratory devices and associated benefits is expected to boost the market in coming years. Adoption of on-demand and continuous Portable Oxygen Concentrator (POC) in a wide range of applications including emergency medicine is emerging as a fresh growth prospect for expansion of the global respiratory devices market.

Registering the application areas, players operating in the global market are consistently working to bring innovation in the product, providing efficient solution and on subsequently reducing the price of units. 

Some of the prominent key players operating in the oxygen therapy devices market are ResMed, Koninklijke Philips N.V, and Vyaire Medical, Inc. (Becton, Dickinson and Company), Smiths Medical (part of Smiths Group plc), Fisher & Paykel Healthcare Limited, Dragerwerk AG & Co. KGaA, GE Healthcare (part of General Electric Company), Getinge AB, Medtronic plc, and Chart Industries, among others

 These companies are introducing products on basis of clinical urgency for greater mobility support for elderly population and growing demand for the portable technology by consumers. Diversified product portfolio is anticipated to gain wide customer traction.

Advent of Technologically Advanced Devices Provide Fresh Growth Prospects to Oxygen Delivery Devices

Further, advent of technologically respiratory devices, which offers efficient patient is projected to accelerate the market growth.  Technologically advancement in delivery devices has resulted in integration of sensors coupled with pulse dose meters. These devices enable to regulate flow of the oxygen. Adoption of respiratory therapy is growing significantly. The growth rate is attributed to the potential benefits offered by the devices. These benefits include faster response rate, efficient dosing, controlled flow, and greater reliability and durability. These aforementioned factors are likely to propel the industry expansion process.

Growing prevalence of respiratory diseases such as sleep apnea and Chronic Obstructive Pulmonary disorder is anticipated to boost market growth. As per a report published by the WHO, nearly 64 million people across the globe suffers from mild to severe COPD. In addition, COPD is found to be third leading cause of death across the world. Rising demand for protracted treatment and emergency treatment associated with lung diseases in children and adults are likely to boost the market growth during the forecast period.

Further, respiratory therapeutics devices are preferred by medical professionals and physicians for treatment of various types of respiratory disorders. These devices provide immediate medical intervention in case of acute and chronic patient care.

North America Accounts for Prominent Share in Global Market

In recent years, North America market has accounted for prominent share in the global respiratory devices market. Prominence of the region is attributed to presence of well-developed healthcare infrastructure, growing awareness among population, and constant technological advancements.

The region is likely to lead in coming years as well, owing to growing patient pool affected by respiratory diseases. Rising prevalence of COPD is anticipated to fuel demand for respiratory devices in the region.

Global Respiratory Devices Market: Overview

Respiratory devices are medical equipment that assist patients with respiration in a critical care situation. Additionally, respiratory devices are used to deliver medicines to treat several respiratory diseases. Moreover, these devices are used to diagnose respiratory problems in patients. Increase in incidence of COPD and sleep apnea, strategic alliance between key players, and rise in government expenditure are the major factors projected to propel the global respiratory devices market during the forecast period. However, high cost of respiratory devices and uncertain and ambiguous regulatory environment hamper the growth of the market.

The report comprises an elaborate executive summary, which includes a market snapshot that provides information about various segments of the market. It also provides information and data analysis of the global market with respect to the segments based on product type, application, and region. A detailed qualitative analysis of drivers and restraints of the market and opportunities has been provided in the overview section. Additionally, the section comprises competitive matrix and company profiles with business overview to understand the competitive landscape in the market. This section of the report also provides market attractiveness analysis by region and market share analysis by key players, thereby presenting a thorough analysis of the overall competitive scenario in the global respiratory devices market.

Global Respiratory Devices Market: Key Segments

In terms of product type, the global respiratory devices market has been segmented into therapeutic devices and diagnostic & monitoring devices. The therapeutic devices segment has been classified into drug delivery devices, mechanical ventilators, continuous positive airway pressure, resuscitators, humidifiers, airway clearance devices, oxygen concentrators, consumables & disposables, and others. The diagnostic & monitoring devices segment has been categorized into pulse oximeters, capnographs, spirometers, polysomnographs, peak flow meters, gas analyzers, and others. Based on application, the market has been divided into chronic obstructive pulmonary disease, asthma, obstructive sleep apnea, respiratory distress syndrome, cystic fibrosis, and pneumonia. The global respiratory devices market has been analyzed based on increasing cases of respiratory diseases, technology trends, expenditure on emerging technology, and presence of key players. The market size and forecast for each of these segments have been provided for the period from 2016 to 2026, along with respective CAGRs for the forecast period from 2018 to 2026, considering 2017 as the base year.

Global Respiratory Devices Market: Regional Outlook

Geographically, the global respiratory devices market has been segmented into five major regions and the key countries in the respective region: North America (the U.S. and Canada), Europe (the U.K., Germany, France, Italy, Spain, and Rest of Europe), Asia Pacific (China, India, Japan, Australia & New Zealand, and Rest of Asia Pacific), Latin America (Brazil, Mexico, and Rest of Latin America), and Middle East & Africa (GCC, South Africa, Israel, and Rest of Middle East & Africa). The market size and forecast for each of these regions and the mentioned countries have been provided for the period from 2016 to 2026, along with their respective CAGRs for the forecast period from 2018 to 2026, considering 2017 as the base year. The research study also covers the competitive scenario in these regions.

Companies Mentioned in Report

The report also profiles major players in the market in terms of attributes such as company overview, financial overview, product portfolio, business strategies, and recent developments. Key companies profiled in the report are ResMed, Inc., Smiths Medical, Fisher & Paykel Healthcare Limited, Dragerwerk AG & Co. KGaA, GE Healthcare, Getinge AB, Medtronic plc, Koninklijke Philips N.V., Chart Industries, and Vyaire Medical, Inc.

This study by TMR is all-encompassing framework of the dynamics of the market. It mainly comprises critical assessment of consumers' or customers' journeys, current and emerging avenues, and strategic framework to enable CXOs take effective decisions.

Our key underpinning is the 4-Quadrant Framework EIRS that offers detailed visualization of four elements:

  • Customer Experience Maps
  • Insights and Tools based on data-driven research
  • Actionable Results to meet all the business priorities
  • Strategic Frameworks to boost the growth journey

The study strives to evaluate the current and future growth prospects, untapped avenues, factors shaping their revenue potential, and demand and consumption patterns in the global market by breaking it into region-wise assessment.

The following regional segments are covered comprehensively:

  • North America
  • Asia Pacific
  • Europe
  • Latin America
  • The Middle East and Africa

The EIRS quadrant framework in the report sums up our wide spectrum of data-driven research and advisory for CXOs to help them make better decisions for their businesses and stay as leaders.

Below is a snapshot of these quadrants.

1. Customer Experience Map

The study offers an in-depth assessment of various customers’ journeys pertinent to the market and its segments. It offers various customer impressions about the products and service use. The analysis takes a closer look at their pain points and fears across various customer touchpoints. The consultation and business intelligence solutions will help interested stakeholders, including CXOs, define customer experience maps tailored to their needs. This will help them aim at boosting customer engagement with their brands.

2. Insights and Tools

The various insights in the study are based on elaborate cycles of primary and secondary research the analysts engage with during the course of research. The analysts and expert advisors at TMR adopt industry-wide, quantitative customer insights tools and market projection methodologies to arrive at results, which makes them reliable. The study not just offers estimations and projections, but also an uncluttered evaluation of these figures on the market dynamics. These insights merge data-driven research framework with qualitative consultations for business owners, CXOs, policy makers, and investors. The insights will also help their customers overcome their fears.

3. Actionable Results

The findings presented in this study by TMR are an indispensable guide for meeting all business priorities, including mission-critical ones. The results when implemented have shown tangible benefits to business stakeholders and industry entities to boost their performance. The results are tailored to fit the individual strategic framework. The study also illustrates some of the recent case studies on solving various problems by companies they faced in their consolidation journey.

4. Strategic Frameworks

The study equips businesses and anyone interested in the market to frame broad strategic frameworks. This has become more important than ever, given the current uncertainty due to COVID-19. The study deliberates on consultations to overcome various such past disruptions and foresees new ones to boost the preparedness. The frameworks help businesses plan their strategic alignments for recovery from such disruptive trends. Further, analysts at TMR helps you break down the complex scenario and bring resiliency in uncertain times.

The report sheds light on various aspects and answers pertinent questions on the market. Some of the important ones are:

1. What can be the best investment choices for venturing into new product and service lines?

2. What value propositions should businesses aim at while making new research and development funding?

3. Which regulations will be most helpful for stakeholders to boost their supply chain network?

4. Which regions might see the demand maturing in certain segments in near future?

5. What are the some of the best cost optimization strategies with vendors that some well-entrenched players have gained success with?

6. Which are the key perspectives that the C-suite are leveraging to move businesses to new growth trajectory?

7. Which government regulations might challenge the status of key regional markets?

8. How will the emerging political and economic scenario affect opportunities in key growth areas?

9. What are some of the value-grab opportunities in various segments?

10. What will be the barrier to entry for new players in the market?

The global respiratory devices market has been segmented as follows:

Product Type

  • Therapeutic Devices
  • Diagnostic & Monitoring Devices

Therapeutic Devices

  • Drug Delivery Devices
    • Nebulizers
    • Inhalers
  • Mechanical Ventilators
    • Invasive
    • Non-Invasive
  • Continuous Positive Airway Pressure
    • Devices
    • Disposables
  • Resuscitators
    • Reusable
    • Disposables
  • Humidifiers
  • Airway Clearance Devices
  • Oxygen Concentrators
  • Consumables & Disposables
  • Others

Diagnostic & Monitoring Devices

  • Pulse Oximeters
  • Capnographs
  • Spirometers
  • Polysomnographs
  • Peak Flow Meters
  • Gas Analyzers
  • Others

Application

  • Chronic Obstructive Pulmonary Disease
  • Asthma
  • Obstructive Sleep Apnea
  • Respiratory Distress Syndrome
  • Cystic Fibrosis
  • Pneumonia

Region

  • North America
    • U.S.
    • Canada
  • Europe
    • Germany
    • U.K.
    • France
    • Italy
    • Spain
    • Rest of Europe
  • Asia Pacific
    • China
    • Japan
    • Australia & New Zealand
    • India
    • Rest of Asia Pacific
  • Latin America
    • Brazil
    • Mexico
    • Rest of Latin America
  • Middle East & Africa
    • GCC
    • South Africa
    • Israel
    • Rest of Middle East & Africa

With a robust experience in creating exceptional market reports, Transparency Market Research has emerged as one of the trusted market research companies among a large number of stakeholders and CXOs. Every report at Transparency Market Research goes through rigorous research activity in every aspect. The researchers at TMR keep a close watch on the market and extract beneficial growth-boosting points. These points help the stakeholders to strategize their business plans accordingly.

TMR researchers conduct exhaustive qualitative and quantitative research. This research involves taking inputs from the experts in the market, focused attention on recent developments, and others. This method of research makes TMR stand out from other market research firms.

Here's how Transparency Market Research helps the stakeholders and CXOs through the reports:

Inculcation and Evaluation of Strategic Collaborations: The TMR researchers analyze recent strategic activities like mergers, acquisitions, partnerships, collaborations, and joint ventures. All the information is compiled and included in the report.

Perfect Market Size Estimations: The report analyzes the demographics, growth potential, and capability of the market through the forecast period. This factor leads to the estimation of the market size and also provides an outline about how the market will retrieve growth during the assessment period.

Investment Research: The report focuses on the ongoing and upcoming investment opportunities across a particular market. These developments make the stakeholders aware of the current investment scenario across the market.

Note: Although care has been taken to maintain the highest levels of accuracy in TMR’s reports, recent market/vendor-specific changes may take time to reflect in the analysis.

1. Preface
     1.1. Market Definition and Scope
     1.2. Market Segmentation
     1.3. Key Research Objectives
     1.4. Research Highlights

2. Assumptions and Research Methodology

3. Executive Summary: Global Respiratory Devices Market

4. Market Overview
     4.1. Introduction
     4.2. Overview
     4.3. Global Respiratory Devices Market Analysis and Forecasts, 2016–2026
            4.3.1. Market Revenue Projections (US$ Mn)
     4.4. Market Dynamics
            4.4.1. Drivers
            4.4.2. Restraints
            4.4.3. Opportunities
            4.3.4. Key Trends

5. Market Outlook
     5.1. Value Chain Analysis
     5.2. Regulatory Framework
     5.3. Porter’s Five Force Analysis

6. Global Respiratory Devices Market Analysis and Forecasts, by Product Type
     6.1. Introduction & Definition
     6.2. Market Value Forecast, by Product Type, 2016–2026
            6.2.1. Therapeutic Devices
            6.2.2. Diagnostic & Monitoring Devices
     6.3. Market Attractiveness Analysis
            6.3.1. Therapeutic Devices
            6.3.2. Diagnostic & Monitoring Devices

7. Global Respiratory Devices Market Analysis and Forecasts, by Therapeutic Devices
     7.1. Introduction & Definition
     7.2. Market Value Forecast, by Therapeutic Devices, 2016–2026
            7.2.1. Drug Delivery Devices
                     7.2.1.1. Nebulizers
                     7.2.1.2. Inhalers
            7.2.2. Mechanical Ventilators
                     7.2.2.1. Invasive
                     7.2.2.2. Non-Invasive
            7.2.3. Continuous Positive Airway Pressure (CPAP)
                     7.2.3.1. Devices
                     7.2.3.2. Disposables
            7.2.4. Resuscitators
                     7.2.4.1. Reusable
                     7.2.4.2. Disposables
            7.2.5. Humidifiers
            7.2.6. Airway Clearance Devices
            7.2.7. Oxygen Concentrators
            7.2.8. Consumables & Disposables
            7.2.9. Others
     7.3. Market Attractiveness by Therapeutic Devices
            7.3.1. Drug Delivery Devices
            7.3.2. Mechanical Ventilators
            7.3.3. Continuous Positive Airway Pressure (CPAP)
            7.3.4. Resuscitators
            7.3.5. Humidifiers
            7.3.6. Airway Clearance Devices
            7.3.7. Oxygen Concentrators
            7.3.8. Consumables & Disposables
            7.3.9. Others

8. Global Respiratory Devices Market Analysis and Forecasts, by Diagnostic & Monitoring Devices
     8.1. Introduction & Definition
     8.2. Market Value Forecast, by Diagnostic & Monitoring Devices, 2016–2026
            8.2.1. Pulse Oximeters
            8.2.2. Capnographs
            8.2.3. Spirometers
            8.2.4. Polysomnographs (PSG)
            8.2.5. Peak Flow Meters
            8.2.6. Gas Analyzers
            8.2.7. Others
     8.3. Market Attractiveness, by Diagnostic & Monitoring Devices
            8.3.1. Pulse Oximeters
            8.3.2. Capnographs
            8.3.3. Spirometers
            8.3.4. Polysomnographs (PSG)
            8.3.5. Peak Flow Meters
            8.3.6. Gas Analyzers
            8.3.7. Others

9. Global Respiratory Devices Market Analysis and Forecasts, by Application
     9.1. Introduction & Definition
     9.2. Market Value Forecast, by Application, 2016–2026
            9.2.1. Chronic Obstructive Pulmonary Disease (COPD)
            9.2.2. Asthma
            9.2.3. Obstructive Sleep Apnea (OSA)
            9.2.4. Respiratory Distress Syndrome (RDS)
            9.2.5. Cystic Fibrosis
            9.2.6. Pneumonia
     9.3. Market Attractiveness, by Application
            9.3.1. Chronic Obstructive Pulmonary Disease (COPD)
            9.3.2. Asthma
            9.3.3. Obstructive Sleep Apnea (OSA)
            9.3.4. Respiratory Distress Syndrome (RDS)
            9.3.5. Cystic Fibrosis
            9.3.6. Pneumonia

10. Global Respiratory Devices Market Analysis and Forecasts, by Region
     10.1. Market Value Share Analysis, by Region
     10.2. Market Value Forecast, by Region
            10.2.1. North America
            10.2.2. Europe
            10.2.3. Asia Pacific
            10.2.4. Latin America
            10.2.5. Middle East & Africa
     10.3. Market Attractiveness, by Region
            10.3.1. North America
            10.3.2. Europe
            10.3.3. Asia Pacific
            10.3.4. Latin America
            10.3.5. Middle East & Africa

11. North America Respiratory Devices Market Analysis and Forecast
     11.1. Introduction
            11.1.1. Key Findings
     11.2. Market Value Forecast, by Product Type, 2016–2026
            11.2.1. Therapeutic Devices
            11.2.2. Diagnostic & Monitoring Devices
     11.3. Market Value Forecast, by Therapeutic Devices, 2016–2026
            11.3.1. Drug Delivery Devices
                     11.3.1.1. Nebulizers
                     11.3.1.2. Inhalers
            11.3.2. Mechanical Ventilators
                     11.3.2.1. Invasive
                     11.3.2.2. Non-Invasive
            11.3.3. Continuous Positive Airway Pressure (CPAP)
                     11.3.3.1. Devices
                     11.3.3.2. Disposables
            11.3.4. Resuscitators
                     11.3.4.1. Reusable
                     11.3.4.2. Disposables
            11.3.5. Humidifiers
            11.3.6. Airway Clearance Devices
            11.3.7. Oxygen Concentrators
            11.3.8. Consumables & Disposables
            11.3.9. Others
     11.4. Market Value Forecast, by Diagnostic & Monitoring Devices, 2016–2026
            11.4.1. Pulse Oximeters
            11.4.2. Capnographs
            11.4.3. Spirometers
            11.4.4. Polysomnographs (PSG)
            11.4.5. Peak Flow Meters
            11.4.6. Gas Analyzers
            11.4.7. Others
     11.5. Market Value Forecast, by Application, 2016–2026
            11.5.1. Chronic Obstructive Pulmonary Disease (COPD)
            11.5.2. Asthma
            11.5.3. Obstructive Sleep Apnea (OSA)
            11.5.4. Respiratory Distress Syndrome (RDS)
            11.5.5. Cystic Fibrosis
            11.5.6. Pneumonia
     11.6. Market Value Forecast, by Country, 2016–2026
            11.6.1. U.S.
            11.6.2. Canada
     11.7. Market Attractiveness Analysis
            11.7.1. By Therapeutic Devices
            11.7.2. By Diagnostic & Monitoring Devices
            11.7.3. By Application
            11.7.4. By Country

12. Europe Respiratory Devices Market Analysis and Forecast
     12.1. Introduction
            12.1.1. Key Findings
     12.2. Market Value Forecast, by Product Type, 2016–2026
            12.2.1. Therapeutic Devices
            12.2.2. Diagnostic & Monitoring Devices
     12.3. Market Value Forecast, by Therapeutic Devices, 2016–2026
            12.3.1. Drug Delivery Devices
                     12.3.1.1. Nebulizers
                     12.3.1.2. Inhalers
            12.3.2. Mechanical Ventilators
                     12.3.2.1. Invasive
                     12.3.2.2. Non-invasive
            12.3.3. Continuous Positive Airway Pressure (CPAP)
                     12.3.3.1. Devices
                     12.3.3.2. Disposables
            12.3.4. Resuscitators
                     12.3.4.1. Reusable
                     12.3.4.2. Disposables
            12.3.5. Humidifiers
            12.3.6. Airway Clearance Devices
            12.3.7. Oxygen Concentrators
            12.3.8. Consumables & Disposables
            12.3.9. Others
     12.4. Market Value Forecast, by Diagnostic & Monitoring Devices, 2016–2026
            12.4.1. Pulse Oximeters
            12.4.2. Capnographs
            12.4.3. Spirometers
            12.4.4. Polysomnographs (PSG)
            12.4.5. Peak Flow Meters
            12.4.6. Gas Analyzers
            12.4.7. Others
     12.5. Market Value Forecast, by Application, 2016–2026
            12.5.1. Chronic Obstructive Pulmonary Disease (COPD)
            12.5.2. Asthma
            12.5.3. Obstructive Sleep Apnea (OSA)
            12.5.4. Respiratory Distress Syndrome (RDS)
            12.5.5. Cystic Fibrosis
            12.5.6. Pneumonia
     12.6. Market Value Forecast, by Country / Sub-region, 2016–2026
            12.6.1. Germany
            12.6.2. France
            12.6.3. U.K.
            12.6.4. Italy
            12.6.5. Spain
            12.6.6. Rest of Europe
     12.7. Market Attractiveness Analysis
            12.7.1. By Therapeutic Devices
            12.7.2. By Diagnostic & Monitoring Devices
            12.7.3. By Application
            12.7.4. By Country/Sub-region

13. Asia Pacific Respiratory Devices Market Analysis and Forecast
     13.1. Introduction
            13.1.1. Key Findings
     13.2. Market Value Forecast, by Product Type, 2016–2026
            13.2.1. Therapeutic Devices
            13.2.2. Diagnostic & Monitoring Devices
     13.3. Market Value Forecast, by Therapeutic Devices, 2016–2026
            13.3.1. Drug Delivery Devices
                     13.3.1.1. Nebulizers
                     13.3.1.2. Inhalers
            13.3.2. Mechanical Ventilators
                     13.3.2.1. Invasive
                     13.3.2.2. Non-Invasive
            13.3.3. Continuous Positive Airway Pressure (CPAP)
                     13.3.3.1. Devices
                     13.3.3.2. Disposables
            13.3.4. Resuscitators
                     13.3.4.1. Reusable
                     13.3.4.2. Disposables
            13.3.5. Humidifiers
            13.3.6. Airway Clearance Devices
            13.3.7. Oxygen Concentrators
            13.3.8. Consumables & Disposables
            13.3.9. Others
     13.4. Market Value Forecast, by Diagnostic & Monitoring Devices, 2016–2026
            13.4.1. Pulse Oximeters
            13.4.2. Capnographs
            13.4.3. Spirometers
            13.4.4. Polysomnographs (PSG)
            13.4.5. Peak Flow Meters
            13.4.6. Gas Analyzers
            13.4.7. Others
     13.5. Market Value Forecast, by Application, 2016–2026
            13.5.1. Chronic Obstructive Pulmonary Disease (COPD)
            13.5.2. Asthma
            13.5.3. Obstructive Sleep Apnea (OSA)
            13.5.4. Respiratory Distress Syndrome (RDS)
            13.5.5. Cystic Fibrosis
            13.5.6. Pneumonia
     13.6. Market Value Forecast, by Country/Sub-region, 2016–2026
            13.6.1. Japan
            13.6.2. China
            13.6.3. India
            13.6.4. Australia & New Zealand
            13.6.5. Rest of APAC
     13.7. Market Attractiveness Analysis
            13.7.1. By Therapeutic Devices
            13.7.2. By Diagnostic & Monitoring Devices
            13.7.3. By Application
            13.7.4. By Country/Sub-region

14. Latin America Respiratory Devices Market Analysis and Forecast
     14.1. Introduction
            14.1.1. Key Findings
     14.2. Market Value Forecast, by Product Type, 2016–2026
            14.2.1. Therapeutic Devices
            14.2.2. Diagnostic & Monitoring Devices
     14.3. Market Value Forecast, by Therapeutic Devices, 2016–2026
            14.3.1. Drug Delivery Devices
                     14.3.1.1. Nebulizers
                     14.3.1.2. Inhalers
            14.3.2. Mechanical Ventilators
                     14.3.2.1. Invasive
                     14.3.2.2. Non-Invasive
            14.3.3. Continuous Positive Airway Pressure (CPAP)
                     14.3.3.1. Devices
                     14.3.3.2. Disposables
            14.3.4. Resuscitators
                     14.3.4.1. Reusable
                     14.3.4.2. Disposables
            14.3.5. Humidifiers
            14.3.6. Airway Clearance Devices
            14.3.7. Oxygen Concentrators
            14.3.8. Consumables & Disposables
            14.3.9. Others
     14.4. Market Value Forecast, by Diagnostic & Monitoring Devices, 2016–2026
            14.4.1. Pulse Oximeters
            14.4.2. Capnographs
            14.4.3. Spirometers
            14.4.4. Polysomnographs (PSG)
            14.4.5. Peak Flow Meters
            14.4.6. Gas Analyzers
            14.4.7. Others
     14.5. Market Value Forecast, by Application, 2016–2026
            14.5.1. Chronic Obstructive Pulmonary Disease (COPD)
            14.5.2. Asthma
            14.5.3. Obstructive Sleep Apnea (OSA)
            14.5.4. Respiratory Distress Syndrome (RDS)
            14.5.5. Cystic Fibrosis
            14.5.6. Pneumonia
     14.6. Market Value Forecast, by Country/Sub-region, 2016–2026
            14.6.1. Brazil
            14.6.2. Mexico
            14.6.3. Rest of LATAM
     14.7. Market Attractiveness Analysis
            14.7.1. By Therapeutic Devices
            14.7.2. By Diagnostic & Monitoring Devices
            14.7.3. By Application
            14.7.4. By Country / Sub-region

15. Middle East & Africa Respiratory Devices Market Analysis and Forecast
     15.1. Introduction
            15.1.1. Key Findings
     15.2. Market Value Forecast, by Product Type, 2016–2026
            15.2.1. Therapeutic Devices
            15.2.2. Diagnostic & Monitoring Devices
     15.3. Market Value Forecast, by Therapeutic Devices, 2016–2026
            15.3.1. Drug Delivery Devices
                     15.3.1.1. Nebulizers
                     15.3.1.2. Inhalers
            15.3.2. Mechanical Ventilators
                     15.3.2.1. Invasive
                     15.3.2.2. Non-Invasive
            15.3.3. Continuous Positive Airway Pressure (CPAP)
                     15.3.3.1. Devices
                     15.3.3.2. Disposables
            15.3.4. Resuscitators
                     15.3.4.1. Reusable
                     15.3.4.2. Disposables
            15.3.5. Humidifiers
            15.3.6. Airway Clearance Devices
            15.3.7. Oxygen Concentrators
            15.3.8. Consumables & Disposables
            15.3.9. Others
     15.4. Market Value Forecast, by Diagnostic & Monitoring Devices, 2016–2026
            15.4.1. Pulse Oximeters
            15.4.2. Capnographs
            15.4.3. Spirometers
            15.4.4. Polysomnographs (PSG)
            15.4.5. Peak Flow Meters
            15.4.6. Gas Analyzers
            15.4.7. Others
     15.5. Market Value Forecast, by Application, 2016–2026
            15.5.1. Chronic Obstructive Pulmonary Disease (COPD)
            15.5.2. Asthma
            15.5.3. Obstructive Sleep Apnea (OSA)
            15.5.4. Respiratory Distress Syndrome (RDS)
            15.5.5. Cystic Fibrosis
            15.5.6. Pneumonia
     15.6. Market Value Forecast, by Country/Sub-region, 2016–2026
            15.6.1. GCC Countries
            15.6.2. South Africa
            15.6.3. Israel
            15.6.4. Rest of MEA
     15.7. Market Attractiveness Analysis
            15.7.1. By Therapeutic Devices
            15.7.2. By Diagnostic & Monitoring Devices
            15.7.3. By Application
            15.7.4. By Country / Sub-region

16. Competition Landscape
     16.1. Market Player - Competition Matrix (By Tier and Size of companies)
     16.2. Company Profiles
            16.2.1. ResMed Inc.
                     16.2.1.1. Company Overview (HQ, Business Segments, Employee Strength)
                     16.2.1.2. Financial Overview
                     16.2.1.3. Product Portfolio
                     16.2.1.4. SWOT Analysis
                     16.2.1.5. Strategic Overview
            16.2.2. Smiths Medical (part of Smiths Group plc)
                     16.2.2.1. Company Overview (HQ, Business Segments, Employee Strength)
            16.2.2..2. Financial Overview
                     16.2.2.3. Product Portfolio
                     16.2.2.4. SWOT Analysis
                     16.2.2.5. Strategic Overview
            16.2.3. Fisher & Paykel Healthcare Limited
                     16.2.3.1. Company Overview (HQ, Business Segments, Employee Strength)
            16.2.3..2. Financial Overview
                     16.2.3.3. Product Portfolio
                     16.2.3.4. SWOT Analysis
                     16.2.3.5. Strategic Overview
            16.2.4. Dragerwerk AG & Co. KGaA
                     16.2.4.1. Company Overview (HQ, Business Segments, Employee Strength)
            16.2.4..2. Financial Overview
                     16.2.4.3. Product Portfolio
                     16.2.4.4. SWOT Analysis
                     16.2.4.5. Strategic Overview
            16.2.5. GE Healthcare (part of General Electric Company)
                     16.2.5.1. Company Overview (HQ, Business Segments, Employee Strength)
            16.2.5..2. Financial Overview
                     16.2.5.3. Product Portfolio
                     16.2.5.4. SWOT Analysis
                     16.2.5.5. Strategic Overview
            16.2.6. Getinge AB
                     16.2.6.1. Company Overview (HQ, Business Segments, Employee Strength)
            16.2.6..2. Financial Overview
                     16.2.6.3. Product Portfolio
                     16.2.6.4. SWOT Analysis
                     16.2.6.5. Strategic Overview
            16.2.7. Medtronic plc
                     16.2.7.1. Company Overview (HQ, Business Segments, Employee Strength)
            16.2.7..2. Financial Overview
                     16.2.7.3. Product Portfolio
                     16.2.7.4. SWOT Analysis
                     16.2.7.5. Strategic Overview
            16.2.8. Koninklijke Philips N.V.
                     16.2.8.1. Company Overview (HQ, Business Segments, Employee Strength)
            16.2.8..2. Financial Overview
                     16.2.8.3. Product Portfolio
                     16.2.8.4. SWOT Analysis
                     16.2.8.5. Strategic Overview
            16.2.9. Chart Industries
                     16.2.9.1. Company Overview (HQ, Business Segments, Employee Strength)
            16.2.9..2. Financial Overview
                     16.2.9.3. Product Portfolio
                     16.2.9.4. SWOT Analysis
                     16.2.9.5. Strategic Overview
            16.2.10. ResMed Inc.
                     16.2.10.1. Company Overview (HQ, Business Segments, Employee Strength)
                     16.2.10.2. Financial Overview
                     16.2.10.3. Product Portfolio
                     16.2.10.4. SWOT Analysis
                     16.2.10.5. Strategic Overview
            16.2.11. Vyaire Medical Inc. (Becton, Dickinson and Company)
                     16.2.11.1. Company Overview (HQ, Business Segments, Employee Strength)
                     16.2.11.2. Financial Overview
                     16.2.11.3. Product Portfolio
                     16.2.11.4. SWOT Analysis
                     16.2.11.5. Strategic Overview

List of Tables 

Table 01: Global Respiratory Devices Market Size (US$ Mn) Forecast, by Product Type, 2016–2026
Table 02: Global Therapeutic Respiratory Devices Market Size (US$ Mn) Forecast, by Device Type, 2016–2026
Table 03: Global Therapeutic Respiratory Devices Market Size (US$ Mn) Forecast, by Drug Delivery Devices, 2016–2026
Table 04: Global Therapeutic Respiratory Devices Market Size (US$ Mn) Forecast, by Mechanical Ventilators, 2016–2026
Table 05: Global Therapeutic Respiratory Devices Market Size (US$ Mn) Forecast, by CPAP, 2016–2026
Table 06: Global Therapeutic Respiratory Devices Market Size (US$ Mn) Forecast, by Resuscitators, 2016–2026
Table 07: Global Diagnostic & Monitoring Respiratory Devices Market Size (US$ Mn) Forecast, by Device Type, 2016–2026
Table 08: Global Respiratory Devices Market Size (US$ Mn) Forecast, by Application, 2016–2026
Table 09: Global Respiratory Devices Market Size (US$ Mn) Forecast, by Region, 2016–2026
Table 10: North America Respiratory Devices Market Size (US$ Mn) Forecast, by Product Type, 2016–2026
Table 11: North America Respiratory Devices Market Size (US$ Mn) Forecast, by Therapeutic Devices Type, 2016–2026
Table 12: North America Respiratory Devices Market Size (US$ Mn) Forecast, by Drug Delivery Device, 2016–2026
Table 13: North America Respiratory Devices Market Size (US$ Mn) Forecast, by Mechanical Ventilator, 2016–2026
Table 14: North America Respiratory Devices Market Size (US$ Mn) Forecast, by C-PAP, 2016–2026
Table 15: North America Respiratory Devices Market Size (US$ Mn) Forecast, by Resuscitator, 2016–2026
Table 16: North America Respiratory Devices Market Size (US$ Mn) Forecast, by Diagnostics & Monitoring Type, 2016–2026
Table 17: North America Respiratory Devices Market Size (US$ Mn) Forecast, by Application, 2016–2026
Table 18: Europe Respiratory Devices Market Size (US$ Mn) Forecast, by Product Type, 2016–2026
Table 19: Europe Respiratory Devices Market Size (US$ Mn) Forecast, by Therapeutic Devices Type, 2016–2026
Table 20: Europe Respiratory Devices Market Size (US$ Mn) Forecast, by Drug Delivery Device, 2016–2026
Table 21: Europe Respiratory Devices Market Size (US$ Mn) Forecast, by Mechanical Ventilators, 2016–2026
Table 22: Europe Respiratory Devices Market Size (US$ Mn) Forecast, by C-PAP, 2016–2026
Table 23: Europe Respiratory Devices Market Size (US$ Mn) Forecast, by Resuscitators, 2016–2026
Table 24: Europe Respiratory Devices Market Size (US$ Mn) Forecast, by Diagnostics & Monitoring Devices, 2016–2026
Table 25: Europe Respiratory Devices Market Size (US$ Mn) Forecast, by Application, 2016–2026
Table 26: Asia Pacific Respiratory Devices Market Size (US$ Mn) Forecast, by Product Type, 2016–2026
Table 27: Asia Pacific Respiratory Devices Market Size (US$ Mn) Forecast, by Therapeutic Devices Type, 2016–2026
Table 28: Asia Pacific Respiratory Devices Market Size (US$ Mn) Forecast, by Drug Delivery Devices, 2016–2026
Table 29: Asia Pacific Respiratory Devices Market Size (US$ Mn) Forecast, by Mechanical Ventilators, 2016–2026
Table 30: Asia Pacific Respiratory Devices Market Size (US$ Mn) Forecast, by C-PAP, 2016–2026
Table 31: Asia Pacific Respiratory Devices Market Size (US$ Mn) Forecast, by Resuscitators, 2016–2026
Table 32: Asia Pacific Respiratory Devices Market Size (US$ Mn) Forecast, by Diagnostics & Monitoring Type, 2016–2026
Table 33: Asia Pacific Respiratory Devices Market Size (US$ Mn) Forecast, by Application, 2016–2026
Table 34: Latin America Respiratory Devices Market Size (US$ Mn) Forecast, by Product Type, 2016–2026
Table 35: Latin America Respiratory Devices Market Size (US$ Mn) Forecast, by Therapeutic Devices Type, 2016–2026
Table 36: Latin America Respiratory Devices Market Size (US$ Mn) Forecast, by Drug Delivery Devices, 2016–2026
Table 37: Latin America Respiratory Devices Market Size (US$ Mn) Forecast, by Mechanical Ventilators, 2016–2026
Table 38: Latin America Respiratory Devices Market Size (US$ Mn) Forecast, by C-PAP, 2016–2026
Table 39: Latin America Respiratory Devices Market Size (US$ Mn) Forecast, by Resuscitators, 2016–2026
Table 40: Latin America Respiratory Devices Market Size (US$ Mn) Forecast, by Diagnostics & Monitoring Type, 2016–2026
Table 41: Latin America Respiratory Devices Market Size (US$ Mn) Forecast, by Application, 2016–2026
Table 42: MEA Respiratory Devices Market Size (US$ Mn) Forecast, by Product Type, 2016–2026
Table 43: MEA Respiratory Devices Market Size (US$ Mn) Forecast, by Therapeutic Devices Type, 2016–2026
Table 44: MEA Respiratory Devices Market Size (US$ Mn) Forecast, by Drug Delivery Devices, 2016–2026
Table 45: MEA Respiratory Devices Market Size (US$ Mn) Forecast, by Mechanical Ventilators, 2016–2026
Table 46: MEA Respiratory Devices Market Size (US$ Mn) Forecast, by C-PAP, 2016–2026
Table 47: MEA Respiratory Devices Market Size (US$ Mn) Forecast, by Resuscitators, 2016–2026
Table 48: MEA Respiratory Devices Market Size (US$ Mn) Forecast, by Diagnostics & Monitoring Type, 2016–2026
Table 49: MEA Respiratory Devices Market Size (US$ Mn) Forecast, by Application, 2016–2026

List of Figures

Figure 01: Global Respiratory Devices Market Size ($ Million) and Distribution by Geography, 2017 and 2026
Figure 02: Global Respiratory Devices
Figure 03: Top 3 Trends
Figure 04: Global Respiratory Devices market, by Region (2017)
Figure 05:  Global Respiratory Devices Market Size (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2016–2026
Figure 06: Market Value Share by Product Type (2017) Value (US$ Mn)
Figure 07: Market Value Share by Application (2017) Value (US$ Mn)
Figure 08: Market Value Share by Geography (2017) Value (US$ Mn)
Figure 09: Value Chain Analysis
Figure 10: Global Respiratory Devices Market Value Share, by Product Type, 2017 and 2026
Figure 11: Global Therapeutic Respiratory Devices Market Value Share, by Device Type, 2017 and 2026
Figure 12: Global Therapeutic Respiratory Devices Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Drug Delivery Devices, 2016–2026
Figure 13: Global Therapeutic Respiratory Devices Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Mechanical Ventilators, 2016–2026
Figure 14: Global Therapeutic Respiratory Devices Market Revenue (US$ Mn) and Y-o-Y Growth (%), by CPAP, 2016–2026
Figure 15: Global Therapeutic Respiratory Devices Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Resuscitators, 2016–2026
Figure 16: Global Therapeutic Respiratory Devices Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Humidifiers, 2016–2026
Figure 17: Global Therapeutic Respiratory Devices Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Airway Clearance Devices, 2016-2026
Figure 18: Global Therapeutic Respiratory Devices Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Oxygen Concentrators, 2016–2026
Figure 19: Global Therapeutic Respiratory Devices Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Consumables & Disposables, 2016-2026
Figure 20: Global Therapeutic Respiratory Devices Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Others, 2016–2026
Figure 21: Global Therapeutic Respiratory Devices Market Attractiveness Analysis, by Device Type, 2018-2026
Figure 22: Global Diagnostic & Monitoring Respiratory Devices Market Value Share, by Device Type, 2017 and 2026
Figure 23: Global Diagnostic & Monitoring Respiratory Devices Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Pulse Oximeters, 2016–2026
Figure 24: Global Diagnostic & Monitoring Respiratory Devices Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Capnographs, 2016–2026
Figure 25: Global Diagnostic & Monitoring Respiratory Devices Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Spirometers, 2016–2026
Figure 26: Global Diagnostic & Monitoring Respiratory Devices Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Polysomnographs (PSG), 2016–2026
Figure 27: Global Diagnostic & Monitoring Respiratory Devices Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Peak Flow Meters, 2016–2026
Figure 28: Global Diagnostic & Monitoring Respiratory Devices Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Gas Analyzers, 2016–2026
Figure 29: Global Diagnostic & Monitoring Respiratory Devices Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Others, 2016–2026
Figure 30: Global Diagnostic & Monitoring Respiratory Devices Market Attractiveness Analysis, by Device Type, 2018-2026
Figure 31: Global Respiratory Devices Market Value Share, by Application, 2017 and 2026
Figure 32: Global Respiratory Devices Market Revenue (US$ Mn) and Y-o-Y Growth (%), by COPD, 2016–2026
Figure 33: Global Respiratory Devices Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Asthma, 2016–2026
Figure 34: Global Respiratory Devices Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Obstructive Sleep Apnea, 2016–2026
Figure 35: Global Respiratory Devices Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Respiratory Distress Syndrome, 2016–2026
Figure 36: Global Respiratory Devices Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Cystic Fibrosis, 2016–2026
Figure 37: Global Respiratory Devices Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Pneumonia, 2016–2026
Figure 38: Global Respiratory Devices Market Attractiveness Analysis, by Application, 2018-2026
Figure 39: Global Respiratory Devices Market Value Share, by Region, 2017 and 2026
Figure 40: Global Respiratory Devices Market Attractiveness Analysis, by Region, 2018-2026
Figure 41: North America Respiratory Devices Market Size (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2016–2026
Figure 42: North America Respiratory Devices Market Share Analysis, by Product Type, 2017 and 2026
Figure 43: North America Respiratory Devices Market Share Analysis, by Therapeutic Devices Types, 2017 and 2026
Figure 44: North America Respiratory Devices Market Attractiveness Analysis, by Therapeutic Devices Type
Figure 45: North America Respiratory Devices Market Share Analysis, by Diagnostics & Monitoring Devices Type, 2017 and 2026
Figure 46: North America Respiratory Devices Market Attractiveness Analysis, by Diagnostics & Monitoring Type
Figure 47: North America Respiratory Devices Market Share Analysis, by Application, 2017 and 2026
Figure 48: North America Respiratory Devices Market Attractiveness Analysis, by Application, 2018-2026
Figure 49: Europe Respiratory Devices Market Size (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2016–2026
Figure 50: Europe Respiratory Devices Market Share Analysis, by Product Type, 2017 and 2026
Figure 51: Europe Respiratory Devices Market Share Analysis, by Therapeutic Devices Type, 2017 and 2026
Figure 52: Europe Respiratory Devices Market Attractiveness Analysis, by Therapeutic Devices
Figure 53: Europe Respiratory Devices Market Share Analysis, by Diagnostics & Monitoring Devices Type, 2017 and 2026
Figure 54: Europe Respiratory Devices Market Attractiveness Analysis, by Diagnostics & Monitoring Type
Figure 55: Europe Respiratory Devices Market Share Analysis, by Application, 2017 and 2026
Figure 56: Europe Respiratory Devices Market Attractiveness Analysis, by Application
Figure 57: Asia Pacific Respiratory Devices Market Size (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2016–2026
Figure 58: Asia Pacific Respiratory Devices Market Share Analysis, by Product Type, 2017 and 2026
Figure 59: Asia Pacific Respiratory Devices Market Share Analysis, by Therapeutic Devices Type, 2017 and 2026
Figure 60: Asia Pacific Respiratory Devices Market Attractiveness Analysis, by Therapeutic Devices Type
Figure 61: Asia Pacific Respiratory Devices Market Share Analysis, by Diagnostics & Monitoring Devices Type, 2017 and 2026
Figure 62: Asia Pacific Respiratory Devices Market Attractiveness Analysis, by Diagnostics & Monitoring Type
Figure 63: Asia Pacific Respiratory Devices Market Share Analysis, by Application, 2017 and 2026
Figure 64: Asia Pacific Respiratory Devices Market Attractiveness Analysis, by Application
Figure 65: Latin America Respiratory Devices Market Size (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2016–2026
Figure 66: Latin America Respiratory Devices Market Share Analysis, by Product Type, 2017 and 2026
Figure 67: Latin America Respiratory Devices Market Share Analysis, by Therapeutic Devices Types, 2017 and 2026
Figure 68: Latin America Respiratory Devices Market Attractiveness Analysis, by Therapeutic Devices Type
Figure 69: Latin America Respiratory Devices Market Share Analysis, by Diagnostics & Monitoring Devices Type, 2017 and 2026
Figure 70: Latin America Respiratory Devices Market Attractiveness Analysis, by Diagnostics & Monitoring Type
Figure 71: Latin America Respiratory Devices Market Share Analysis, by Application, 2017 and 2026
Figure 72: Latin America Respiratory Devices Market Attractiveness Analysis, by Application
Figure 73: MEA Respiratory Devices Market Size (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2016–2026
Figure 74: MEA Respiratory Devices Market Share Analysis, by Product Type, 2017 and 2026
Figure 75: MEA Respiratory Devices Market Share Analysis, by Therapeutic Devices Types, 2017 and 2026
Figure 76: MEA Respiratory Devices Market Attractiveness Analysis, by Therapeutic Devices Type
Figure 77: MEA Respiratory Devices Market Share Analysis, by Diagnostics & Monitoring Devices Type, 2017 and 2026
Figure 78: MEA Respiratory Devices Market Attractiveness Analysis, by Diagnostics & Monitoring Type
Figure 79: MEA Respiratory Devices Market Share Analysis, by Application, 2017 and 2026
Figure 80: MEA Respiratory Devices Market Attractiveness Analysis, by Application
Figure 81: Global Respiratory Devices Market Share Analysis, by Company (2017)

Custom Market Research Services

TMR offers custom market research services that help clients to get information on their business scenario required where syndicated solutions are not enough.

Request Customization

Respiratory Devices Market